Mauricio Valdes, MD
Orthopaedic Surgery · Tempe, AZNPI 1396964516
Payments from drug & device makers
Across 71 payments — averaging $172.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kuros Biosciences USA, Inc$10K
- Globus Medical$1K
- Medacta USA, Inc.$262
- Seaspine Orthopedics Corporation$230
- Johnson & Johnson$171
- Smith+Nephew$145
- plus $520 from 13 others
What the payments were for
- Consulting fees$7,65062%
- Travel & lodging$2,10617%
- Food & beverage$2,50320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kuros Biosciences USA, Inc | 7 | $9,683 |
| Globus Medical | 19 | $1,247 |
| Medacta USA, Inc. | 3 | $262 |
| Seaspine Orthopedics Corporation | 5 | $230 |
| Johnson & Johnson(2 entities) | 4 | $171 |
| Smith+Nephew | 5 | $145 |
| Amgen | 5 | $135 |
| GSK | 5 | $97 |
| Pacira Therapeutics, Inc. | 5 | $90 |
| Surgalign Spine Technologies, Inc. | 1 | $47 |
| Stryker | 3 | $43 |
| Boston Scientific | 2 | $25 |
| Providence Medical Technology, Inc. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $13 |
| Nevro Corp. | 1 | $12 |
| Theragen, Inc. | 1 | $12 |
| Medtronic | 1 | $11 |
| Terumo BCT, Inc. | 1 | $10 |
| Orthofix Medical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MagnetOs$9,478
- Excelsius - GPS$642
- Skipjack$131
- MUST$123
- MYSPINE$123
- MARS$118
- SYNFIX Evolution$115
- VIPER$115
- CREO$108
How this compares
$12,258 in reported general payments places this provider in the 70th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 50 | $702 |
| Tramadol Hcl | 58 | $573 |
| Tizanidine Hcl | 88 | $547 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 23 | $249 |
| Diclofenac Sodium | 22 | $212 |
| Celecoxib | 20 | $197 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tempe
- Joseph GimbelPhoenix$19.4M
- Evan LedermanPhoenix$13.4M
- James ChowPhoenix$6.2M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$1.1M
- Mark CampbellSun City West$894K
- Maegen WallacePhoenix$832K
- John LankenauLake Havasu City$669K
- Paul GauseScottsdale$614K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.